<?xml version='1.0' encoding='utf-8'?>
<document id="16809802"><sentence text="Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine."><entity charOffset="84-96" id="DDI-PubMed.16809802.s1.e0" text="cyclosporine" /></sentence><sentence text="Furanocoumarins increase the bioavailability of drugs that are CYP3A4 substrates" /><sentence text=" A possible interaction of methoxsalen with cyclosporine was evaluated in 12 healthy volunteers following oral administration of 40 mg methoxsalen, 200 mg cyclosporine, or a combination of both in a randomized crossover study"><entity charOffset="27-38" id="DDI-PubMed.16809802.s3.e0" text="methoxsalen" /><entity charOffset="44-56" id="DDI-PubMed.16809802.s3.e1" text="cyclosporine" /><entity charOffset="135-146" id="DDI-PubMed.16809802.s3.e2" text="methoxsalen" /><entity charOffset="155-167" id="DDI-PubMed.16809802.s3.e3" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e0" e2="DDI-PubMed.16809802.s3.e0" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e0" e2="DDI-PubMed.16809802.s3.e1" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e0" e2="DDI-PubMed.16809802.s3.e2" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e0" e2="DDI-PubMed.16809802.s3.e3" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e1" e2="DDI-PubMed.16809802.s3.e1" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e1" e2="DDI-PubMed.16809802.s3.e2" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e1" e2="DDI-PubMed.16809802.s3.e3" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e2" e2="DDI-PubMed.16809802.s3.e2" /><pair ddi="false" e1="DDI-PubMed.16809802.s3.e2" e2="DDI-PubMed.16809802.s3.e3" /></sentence><sentence text=" Methoxsalen increased area under the plasma concentration-time curve (AUC) and peak plasma concentration (Cmax) of cyclosporine by 29% (range, -20% to 172%; P &lt; "><entity charOffset="1-12" id="DDI-PubMed.16809802.s4.e0" text="Methoxsalen" /><entity charOffset="116-128" id="DDI-PubMed.16809802.s4.e1" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.16809802.s4.e0" e2="DDI-PubMed.16809802.s4.e0" /><pair ddi="false" e1="DDI-PubMed.16809802.s4.e0" e2="DDI-PubMed.16809802.s4.e1" /></sentence><sentence text="05) and 8% (range, -10% to 26%; P &lt; " /><sentence text="05), respectively, compared to cyclosporine alone"><entity charOffset="31-43" id="DDI-PubMed.16809802.s6.e0" text="cyclosporine" /></sentence><sentence text=" The AUC geometric means ratio (95% confidence interval) for cyclosporine plus methoxsalen/cyclosporine alone was 1"><entity charOffset="61-73" id="DDI-PubMed.16809802.s7.e0" text="cyclosporine" /><entity charOffset="79-90" id="DDI-PubMed.16809802.s7.e1" text="methoxsalen" /><entity charOffset="91-103" id="DDI-PubMed.16809802.s7.e2" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.16809802.s7.e0" e2="DDI-PubMed.16809802.s7.e0" /><pair ddi="false" e1="DDI-PubMed.16809802.s7.e0" e2="DDI-PubMed.16809802.s7.e1" /><pair ddi="false" e1="DDI-PubMed.16809802.s7.e0" e2="DDI-PubMed.16809802.s7.e2" /><pair ddi="false" e1="DDI-PubMed.16809802.s7.e1" e2="DDI-PubMed.16809802.s7.e1" /><pair ddi="false" e1="DDI-PubMed.16809802.s7.e1" e2="DDI-PubMed.16809802.s7.e2" /></sentence><sentence text="14 (1" /><sentence text="02, 1" /><sentence text="27), and treatments were therefore not bioequivalent" /><sentence text=" Methoxsalen causes a clinically significant interaction with cyclosporine in some susceptible individuals"><entity charOffset="1-12" id="DDI-PubMed.16809802.s11.e0" text="Methoxsalen" /><entity charOffset="62-74" id="DDI-PubMed.16809802.s11.e1" text="cyclosporine" /><pair ddi="false" e1="DDI-PubMed.16809802.s11.e0" e2="DDI-PubMed.16809802.s11.e0" /><pair ddi="false" e1="DDI-PubMed.16809802.s11.e0" e2="DDI-PubMed.16809802.s11.e1" /></sentence><sentence text=" The reasons for susceptibility and the clinical implications for chronic cyclosporine administration have not been established"><entity charOffset="74-86" id="DDI-PubMed.16809802.s12.e0" text="cyclosporine" /></sentence><sentence text=" Caution is recommended in combination therapy, and more frequent monitoring of cyclosporine plasma levels and clinical monitoring is advised"><entity charOffset="80-92" id="DDI-PubMed.16809802.s13.e0" text="cyclosporine" /></sentence><sentence text="" /></document>